Department of Molecular Biology, Institute for Biological Research, University of Belgrade, Bulevar Despota Stefana 142, 11060 Belgrade, Serbia.
Br J Nutr. 2013 Aug 28;110(3):401-12. doi: 10.1017/S0007114512005429. Epub 2013 Jan 14.
The present study aimed to investigate the effects of the treatment with a-lipoic acid (LA), a naturally occurring compound possessing antioxidant activity, on liver oxidant stress in a rat model of streptozotocin (STZ)-induced diabetes by examining potential mechanistic points that influence changes in the expression of antioxidant enzymes such as catalase (CAT) and CuZn/Mn superoxide dismutase(s) (SOD). LA was administered for 4 weeks by daily intraperitoneal injections (10 mg/kg) to STZ-induced diabetic rats, starting from the last STZ treatment. LA administration practically normalised the activities of the indicators of hepatocellular injury, alanine and aspartate aminotransferases, and lowered oxidative stress, as observed by the thiobarbituric acid-reactive substance assay, restored the reduced glutathione:glutathione disulphide ratio and increased the protein sulfhydryl group content. The lower level of DNA damage detected by the comet assay revealed that LA reduced cytotoxic signalling, exerting a hepatoprotective effect. The LA-treated diabetic rats displayed restored specific enzymatic activities of CAT, CuZnSOD and MnSOD. Quantitative real-time PCR analysis showed that LA restored CAT gene expression to its physiological level and increased CuZnSOD gene expression, but the gene expression of MnSOD remained at the diabetic level. Although the amounts of CAT and CuZnSOD protein expression returned to the control levels, the protein expression of MnSOD was elevated. These results suggested that LA administration affected CAT and CuZnSOD expression mainly at the transcriptional level, and MnSOD expression at the post-transcriptional level. The observed LA-promoted decrease in the O-GlcNAcylation of extracellular signal-regulated kinase, protein 38 kinase, NF-kB, CCAAT/enhancer-binding protein and the antioxidative enzymes themselves in diabetic rats suggests that the regulatory mechanisms that supported the changes in antioxidative enzyme expression were also influenced by post-translational mechanisms.
本研究旨在通过研究影响抗氧化酶(如过氧化氢酶 (CAT) 和铜锌/锰超氧化物歧化酶 (SOD))表达变化的潜在机制点,探讨自然存在的具有抗氧化活性的化合物 α-硫辛酸 (LA) 对链脲佐菌素 (STZ) 诱导的糖尿病大鼠肝脏氧化应激的治疗作用。LA 通过腹腔内每日注射(10mg/kg)给药 4 周,从最后一次 STZ 处理开始,给予 STZ 诱导的糖尿病大鼠。LA 给药实际上使丙氨酸转氨酶和天冬氨酸转氨酶等肝细胞损伤标志物的活性正常化,并降低了氧化应激,如通过硫代巴比妥酸反应物质测定法观察到的,还原型谷胱甘肽:谷胱甘肽二硫化物比和增加蛋白质巯基含量。彗星试验检测到的 DNA 损伤水平较低表明,LA 减少了细胞毒性信号,发挥了肝保护作用。用 LA 治疗的糖尿病大鼠显示 CAT、CuZnSOD 和 MnSOD 的特定酶活性得到恢复。实时定量 PCR 分析显示,LA 将 CAT 基因表达恢复到生理水平并增加了 CuZnSOD 基因表达,但 MnSOD 基因表达仍保持在糖尿病水平。尽管 CAT 和 CuZnSOD 蛋白表达量恢复到对照水平,但 MnSOD 蛋白表达量升高。这些结果表明,LA 给药主要通过转录水平影响 CAT 和 CuZnSOD 的表达,而通过转录后水平影响 MnSOD 的表达。观察到的 LA 促进糖尿病大鼠细胞外信号调节激酶、蛋白 38 激酶、NF-kB、CCAAT/增强子结合蛋白和抗氧化酶本身的 O-GlcNAc 化减少表明,支持抗氧化酶表达变化的调节机制也受到翻译后机制的影响。